ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
about
Molecular and cellular changes in the lumbar spinal cord following thoracic injury: regulation by treadmill locomotor trainingADAM8 as a drug target in pancreatic cancer.Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancerCharacterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15.Testing an aflatoxin B1 gene signature in rat archival tissues.β-Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defectsBone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases.Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.Membrane-anchored proteases in endothelial cell biology.A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease.Synergistic Regulation of Angiogenic Sprouting by Biochemical Factors and Wall Shear Stress.qFlow Cytometry-Based Receptoromic Screening: A High-Throughput Quantification Approach Informing Biomarker Selection and Nanosensor Development.Leukocyte adhesion molecules in diabetic retinopathy.Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases.Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination.Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.Neuronal ADAM10 Promotes Outgrowth of Small-Caliber Myelinated Axons in the Peripheral Nervous System.The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
P2860
Q27323020-DBDEEF66-B474-480C-B32E-43A23C24FF9CQ27324447-706AED86-313F-416C-8D32-76D6011C6BC4Q34076570-9AA69B0C-7891-4917-9E62-2D9E41771092Q34406075-5978F7B8-644C-48C8-8C27-C8FF531A0FB9Q35981453-04EC4B24-91D3-491F-BA1D-F1180811389BQ36385744-E033C01D-A2AA-49C8-95E0-327CA07F43BBQ36402724-70790079-E907-4B9F-AA3E-E6BF15E02474Q36581303-8240E9ED-586D-4AFD-ADDC-DCEAB2D2320BQ36940312-DFE2C922-99C3-43C1-8005-3B62BAB71348Q37082206-4ECA0500-1085-4E2F-9A0D-7C3F129C20C8Q37976074-24B7522A-BAB9-4079-A31D-088F223413A1Q38941700-B61094BB-954A-4F66-81AD-893A6162E41FQ39111812-A6FF6522-1F5E-48C9-A2B0-7F6AF2DCF1E9Q39162354-BC2D7AD4-F86E-4DCC-A8DE-1017B68E71D0Q40687892-0B452709-E66A-41AD-999A-7FD4F967423CQ48543248-28833E81-7B8F-4540-B40F-2DD855DCAC20Q53325569-C3736616-6402-46FB-9080-829141167115Q53644880-C8BD6D83-6A37-428B-997D-72C7B0CF5664
P2860
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@en
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@nl
type
label
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@en
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@nl
prefLabel
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@en
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@nl
P2093
P2860
P1476
ADAM8 is a negative regulator ...... injected tumor cells in mice.
@en
P2093
Carl P Blobel
Gisela Weskamp
Jörg W Bartsch
Patricio Guaiquil
Steven Swendeman
Victor H Guaiquil
Wenhui Zhou
P2860
P2888
P304
P356
10.1007/S00109-010-0591-8
P577
2010-01-30T00:00:00Z